share_log

B of A Securities Upgrades Revolution Medicines to Buy, Announces $34 Price Target

Benzinga ·  Jan 5 08:02

B of A Securities analyst Alec Stranahan upgrades Revolution Medicines (NASDAQ:RVMD) from Neutral to Buy and announces $34 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment